Syngene International Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Scientific research and development

Incorporated: 1993

Chairman: --

Managing Director: Kiran Mazumdar Shaw

Group: --

Listing: NSE: SYNGENE, BSE: 539268

Headquarters: Bengaluru, Karnataka

Website: www.syngeneintl.com

Key Facts

Market cap: R 14,726.00 Cr

Revenue (TTM): R 2,011.90 Cr

Earnings (TTM): R 412.10 Cr

Cash: R 1,152.90 Cr

Total Debt: R 813.30 Cr

Promoters' ownership: 70.69%

Liquidity: High

52 Week range: R 212.55 - 390.00

Face value: R10.00

Shares outstanding: 40,00,00,000

10 Years Aggregate:

CFO: 2,526.08 Cr
EBITDA: 2,678.01 Cr
Net Profit: 1,703.41 Cr

Stock Performance

Trailing
Annual

Time Period	Syngene International	S&P BSE Healthcare	S&P BSE Mid Cap
YTD	14.63	20.33	-16.13
1 month	16.54	6.87	10.21
3 months	22.25	14.23	-13.84
1 Year	7.68	21.43	-17.32
3 Years	15.07	5.22	-5.38
5 Years	--	0.31	3.92
10 Years	--	11.35	6.18

As on 05-Jun-2020

Year	Syngene International	S&P BSE Mid Cap	S&P BSE Healthcare
2019	14.86	-3.05	-3.55
2018	3.46	-13.31	-5.89
2017	-3.65	48.13	0.49
2016	34.51	7.97	-12.88

Annual Report (FY18)

Review & Analysis

Decoding capital expenditure
Research Desk . 08-Nov-2018

News & Announcements